Entry |
|
Name |
Dopamine-DRD-GNAI/O signaling pathway
|
Definition |
Dopamine -> DRD -> (GNAI,GNAO) -| ADCY5 |
Expanded |
C03758 -> (1813,1814,1815) -> ((2770,2771,2773),2775) -| 111 |
Class |
nt06544 Neuroactive ligand signaling
|
Type |
Reference
|
Pathway |
|
Gene |
1813 | DRD2; dopamine receptor D2 |
1814 | DRD3; dopamine receptor D3 |
1815 | DRD4; dopamine receptor D4 |
2770 | GNAI1; G protein subunit alpha i1 |
2771 | GNAI2; G protein subunit alpha i2 |
2773 | GNAI3; G protein subunit alpha i3 |
2775 | GNAO1; G protein subunit alpha o1 |
111 | ADCY5; adenylate cyclase 5 |
|
Metabolite |
|
Reference |
|
Authors |
Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ |
Title |
Dopamine, Immunity, and Disease. |
Journal |
|
Reference |
|
Authors |
Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG |
Title |
Dopamine: Functions, Signaling, and Association with Neurological Diseases. |
Journal |
|
LinkDB |
|